Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Global Longlife Hospital & Research PB Ratio?
Global Longlife Hospital & ResearchBOM:543520 -1.81%36 PB Ratio is 0.58 as of Aug. 08, 2026, which is 40% below its 10-year median of 0.96. GuruFocus rates BOM:543520 with a GF Score™ of 36/100 and a GF Value™ of ₹1.37 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 609 Healthcare Providers & Services companies, Global Longlife Hospital & Research ranks better than 91.63% on this metric.
BOM:543520's PB Ratio is ranked better than 91.63% of 609
companies
in the Healthcare Providers & Services industry
Industry Median: 2.05
vs BOM:543520: 0.53
During the past 12 months, Global Longlife Hospital & Research's average Book Value Per Share Growth Rate was -11.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -28.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 9.60% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Global Longlife Hospital & Research was 77.50% per year. The lowest was -28.20% per year. And the median was 16.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Global Longlife Hospital & Research PB Ratio Related Terms
Global Longlife Hospital & Research PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Longlife Hospital & Research PB Ratio Chart
For the Medical Care Facilities subindustry, Global Longlife Hospital & Research's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Longlife Hospital & Research PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Longlife Hospital & Research's PB Ratio distribution charts can be found below:
* The bar in red indicates where Global Longlife Hospital & Research's PB Ratio falls into.
Global Longlife Hospital & Research PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Global Longlife Hospital & Research (BOM:543520) has a PB Ratio of 0.58 as of Aug. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Global Longlife Hospital & Research and its competitors. This is 40% below median its historical median of 0.96. Over the past decade, Global Longlife Hospital & Research's PB Ratio has ranged from 0.39 to 7.96. According to the industry distribution chart, Global Longlife Hospital & Research ranks #51 out of 609 companies in the Healthcare Providers & Services industry, placing it in the top 8.4%.
Is Global Longlife Hospital & Research's PB Ratio too high?
Global Longlife Hospital & Research's current PB Ratio of 0.58 is 40% below median its 10-year median of 0.96. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 7.96. The Healthcare Providers & Services industry median PB Ratio is 2.05. Global Longlife Hospital & Research's value of 0.58 is 71.7% below this industry median. Based on the distribution chart, Global Longlife Hospital & Research ranks #51 out of 609 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Global Longlife Hospital & Research has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Global Longlife Hospital & Research's PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Longlife Hospital & Research ranks #51 out of 609 companies for PB Ratio. This places Global Longlife Hospital & Research in the top 8% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.05. Global Longlife Hospital & Research's value of 0.58 is 71.7% below this benchmark. Historically, Global Longlife Hospital & Research's own PB Ratio has ranged from 0.39 to 7.96 over the past decade. While the company's 10-year median is 0.96 vs. the industry median of 2.05, Global Longlife Hospital & Research has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.05, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Global Longlife Hospital & Research's current PB Ratio of 0.58 is 71.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Global Longlife Hospital & Research and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Longlife Hospital & Research's current PB Ratio is 0.58, which is 40% below median its own 10-year median of 0.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Longlife Hospital & Research stock overvalued right now?
Based on GuruFocus' analysis, Global Longlife Hospital & Research (BOM:543520) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1.37, compared to a current price of ₹13.04 — trading 851.8% above its estimated fair value. The current PB Ratio is 0.58, which is 40% below median its 10-year median of 0.96 and 71.7% below the Healthcare Providers & Services industry median of 2.05. Global Longlife Hospital & Research's overall GF Score™ is 36/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Global Longlife Hospital & Research (BOM:543520), the current PB Ratio is 0.58 as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Longlife Hospital & Research (BOM:543520) Overvalued in 2026?
Based on GuruFocus' analysis, Global Longlife Hospital & Research stock appears to be overvalued.
The current stock price of ₹13.04 is trading 851.8% above its estimated GF Value™ of ₹1.37.
GuruFocus considers Global Longlife Hospital & Research to be Significantly Overvalued.
Key valuation signals for BOM:543520:
PB Ratio: 0.58 (40% below median its 10-year median of 0.96)
GF Value™: ₹1.37 vs. price of ₹13.04 (851.8% above fair value)
Industry Position: 71.7% below the Healthcare Providers & Services median (#51 of 609)
No single metric tells the full story. See the BOM:543520 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Longlife Hospital & Research Ltd is Multispecialty Hospital providing Medical & Allied Services. The company operates in the single segment i.e. Health Care and Hospital. Its services are Medical, Surgical, Radiology, Pathology, and Other Services.
36GF Score
Get the complete analysis for BOM:543520
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543520 has been successfully added to your 
